• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC EUROPE SARL ACTIVA; IMPLANTED SUBCORTICAL ELECTRICAL STIMULATOR (MOTOR DISORDERS)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC EUROPE SARL ACTIVA; IMPLANTED SUBCORTICAL ELECTRICAL STIMULATOR (MOTOR DISORDERS) Back to Search Results
Model Number 37601
Device Problem Migration or Expulsion of Device (1395)
Patient Problems Neurological Deficit/Dysfunction (1982); Neck Pain (2433)
Event Date 01/26/2016
Event Type  Injury  
Manufacturer Narrative
Other applicable components are: product id: 3389-40, lot# 0208002645, implanted: (b)(6) 2014, product type: lead.Product id: 3389-40, lot# 0207784005, implanted: (b)(6) 2014, product type: lead.
 
Event Description
A healthcare professional from a clinical study reported during normal use on (b)(6) 2015 the patient had worsening cervical dystonia and cervical pain.Diagnostics included examination and device interrogation which was normal for the subject.Actions taken included reprogramming and increase dosage of rivotril medication.No surgical intervention was required and it was unknown if any was planned.The event was related to programming/stimulation.The outcome was ongoing.Patient¿s medical history included hypertension, dyslipidemia, hyperlipidemia, non-statin oral medications, type ii diabetes, oral medications, diet, thyroid disorder, depression, dystonia and the patient was currently taking movement disorder and/or psychiatric medications.Additional information received reported a diagnostic examination was performed to identify the pain and cervical dystonia on (b)(6) 2016.Additional information received september 6, 2016 reported that the patient had an examination (b)(6) 2016 that identified cervical dystonia.Additional information was received from a health care provider (hcp) of a clinical study.It was reported that the diagnostic methods included an examination on (b)(6) 2016 that resulted in the identification of the issue.Imaging was performed on (b)(6) 2016 and resulted in suspicion that the leads migrated; the results are pending.No further complications were reported/anticipated.
 
Manufacturer Narrative
A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Additional information was received from a health care provider (hcp) of a clinical study.It was reported that the actions/interventions taken to resolve the event included repositioning the electrodes in a bilateral thalamic position; no post-traumatic lesion was visualized.No further complications were reported/anticipated.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Additional information was received from a healthcare provider (hcp).It was reported that the last reprogramming session the patient underwent was in (b)(6) 2017.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Additional information was received from a health care provider (hcp).The patient was reprogrammed on (b)(6) 2018.The cervical dystonia is still present.No further complications anticipated.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Additional information was received from a health care provider (hcp).It was reported that the patient was reprogrammed on (b)(6) 2019 and cervical dystonia was still present with blepharospasm.The patient had dysport injections.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACTIVA
Type of Device
IMPLANTED SUBCORTICAL ELECTRICAL STIMULATOR (MOTOR DISORDERS)
Manufacturer (Section D)
MEDTRONIC EUROPE SARL
route du molliau 31
case postale
tolochenaz vaud 1131
CH  1131
Manufacturer (Section G)
MEDTRONIC EUROPE SARL
route du molliau 31
case postale
tolochenaz vaud 1131
CH   1131
Manufacturer Contact
lisa woodward clark
7000 central avenue ne rcw215
minneapolis, MN 55432
7635263920
MDR Report Key6417323
MDR Text Key70359881
Report Number9614453-2017-00915
Device Sequence Number1
Product Code MRU
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
H020007
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Health Professional
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date 10/08/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/20/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/14/2015
Device Model Number37601
Device Catalogue Number37601
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/08/2020
Date Device Manufactured11/18/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age57 YR
Patient Weight82
-
-